A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy

Huibrie C. Pieters, Emily Green, Sally Khakshooy, Miriam Sleven, Annette L. Stanton, M Barton Laws
2019 PLoS ONE  
It remains unclear how information about aromatase inhibitors (AI) impacts women's decision-making about persistence with endocrine therapy.
doi:10.1371/journal.pone.0210972 pmid:30703119 pmcid:PMC6354984 fatcat:tez3tkr4yng3hfcl3bqouhqqpe